Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
Rank in Stocks #14729
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
Share Price
$34.40
Last synced: 2025-08-11
Market Cap
$396.01M
Change (1 day)
1.83%
Change (1 year)
0.00%
Country
DE
Trade PharmaSGP Holding SE (PSG)

Category

Price of PSG with the market cap of B
PharmaSGP Holding SE PharmaSGP Holding SE
PSG
$34.40
Market Capitalization of PharmaSGP Holding SE(PSG)
Market Cap: $396.01M
As of September 2026 PharmaSGP Holding SE has a market cap of $396.01M. This makes PharmaSGP Holding SE the world's 14729th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of PharmaSGP Holding SE from 2011 to 2026
PSG compared with Top 5 Most Popular stocks
Price of PSG Asset B Mkt. of B Results
PharmaSGP Holding SE PharmaSGP Holding SE
$462,697 $396.01M
$5.327T +1,345,009.15%
PharmaSGP Holding SE PharmaSGP Holding SE
$403,464 $396.01M
$4.645T +1,172,810.86%
PharmaSGP Holding SE PharmaSGP Holding SE
$353,551 $396.01M
$4.070T +1,027,710.47%
PharmaSGP Holding SE PharmaSGP Holding SE
$328,737 $396.01M
$3.785T +955,571.34%
PharmaSGP Holding SE PharmaSGP Holding SE
$242,356 $396.01M
$2.790T +704,453.82%